Evidence map›Paper›PMID 19375647›Full record

ArticleExperimental hematology2009

Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells.

Emilia Stellacci, Antonella Di Noia, Angela Di Baldassarre, Giovanni Migliaccio, Angela Battistini, Anna Rita Migliaccio

Open access · greenAbstract read
In one paragraph

Article in Experimental hematology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lipid composition of the cancer cell membrane.Journal of bioenergetics and biomembranes · 2020
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Emilia StellacciDepartment of Infectious, Parasitic and Immunomediated Diseases, University of Chieti-Pescara, Chieti, Italy.
Antonella Di Noia
Angela Di Baldassarre
Giovanni Migliaccio
Angela Battistini
Anna Rita Migliaccio
University of Chieti-Pescara · ITIstituto Superiore di Sanità · IT

Funding

Tissue BankP01CA108671 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Ronald Hoffman · 2006 to 2026
$82.0M
NCI NIH HHS P01 CA108671NCI NIH HHS P01-CA108671
6 · The paper itself

Abstract

objectiveThe aim of this study was to identify whether the rapid membrane-associated pathway of the glucocorticoid receptor (GR) is active in erythroid cells and plays any role in determining the reversible inhibition on erythroid maturation exerted by GR. MATERIALS AND

methodsFirst we determined the biological effects (inhibition of apoptosis and induction of beta-globin expression) induced in primary erythroblasts by erythropoietin (EPO) and the GR agonist dexamethasone (DXM), alone and in combination. Next, by biochemical analysis, we determined the association between GR and EPO receptor in proerythroblasts generated in vitro from 10 normal adult donors. These studies also analyzed the levels of signal transducers and activators of transcription-5 (STAT-5) phosphorylation induced when the cells were stimulated with DXM alone or in combination with EPO.

resultsDXM antagonized the beta-globin messenger RNA increases, but not the inhibition of apoptosis induced by EPO in primary cells. DXM also antagonized the ability of EPO to induce STAT-5 phosphorylation in these cells. In fact, EPO and DXM alone, but not in combination, induced phosphorylation and nuclear translocation of STAT-5. The inhibition likely occurred through an interaction between the two receptors because GR became associated with the EPO receptor and STAT-5 in cells stimulated with EPO and DXM.

conclusionThese data suggest that glucocorticoids inhibit erythroid maturation not only through a transcriptional mechanism, but also through a rapid membrane-associated pathway that interferes with EPO receptor signaling.

Indexed as

Active Transport, Cell NucleusAdultbeta-GlobinsCell NucleusDexamethasoneErythroblastsErythropoietinFemaleGlucocorticoidsHumansMalePhosphorylationReceptors, ErythropoietinReceptors, GlucocorticoidRNA, MessengerSTAT5 Transcription Factorbeta-GlobinsDexamethasoneErythropoietinGlucocorticoidsReceptors, ErythropoietinReceptors, GlucocorticoidRNA, MessengerSTAT5 Transcription Factor

Identifiers

PMID19375647
PMCPMC2689622
OpenAlexW2009361945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.